InMed Pharmaceuticals Inc. (INM) announced its Chief Financial Officer, Bruce Colwill, will be retiring, effective March 31, 2022. Colwill will continue to serve as an advisor through June 30, 2022. Ms. Brenda Edwards has been appointed as Interim Chief Financial Officer, effective April 1, 2022. The company said it has initiated a search for a full time replacement.
Edwards has over 35 years experience including over 20 years as a Chief Financial Officer of both private and public companies. She is a member of both the American Institute of CPAs and the Chartered Professional Accountants of Canada.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.